  
Chlorhexadine Gluconate 2%, Miconazole Nitrate 2%
Clinical trials have shown Malaseb to be an effective treatment and control of seborrheic dermatitis associated with Malessezia pachydermatis and Staphylococcus intermedius.
In combination with systemic therapy, Malaseb was shown to accelerate the resolution of Microsporum Canis clinical signs, thus reducing the risk of transmission of the disease to other animals and to humans in contact with them.
|
